Category: Newsletters

Blue Horseshoe Stocks: GILD Options, RCHA & More


Gilead Sciences, Inc. GILD – Options

Our interest in the GILD $97 and $98 Calls which we featured in yesterday’s morning report paid off big-time for us. With GILD breaking the $100-mark, those contracts provided us with ample opportunity to profit.

The $97 Calls went on a major run from a low of 1.15-3.75, an intraday spike of 226%, while the $98’s made a mammoth move from .75-2.65, registering as an impressive 253% romp. Daily charts for both sets of contracts appear on the snapshot below:

GILD will keep our attention as we head into week’s end, we’ll continue to monitor these $97-98 Weeklies, and should it appear that the stock wants to surge higher we may consider rolling up our strike price to the $99-100 Calls.


Rich Pharmaceuticals, Inc. RCHA

For the second day in a row yesterday, the importance of checking our blog daily stood out with another stock off of our Stock Tracker making huge gains. RCHA went on a historical run from super-subpenny (.0009) to .0163, an intraday gain of more than 1700%

We were also talking about RCHA in both our Premium and Free Skype chatrooms*, where members could have gotten in as low as .0019. Plenty of time to attain gains on the order of several hundred percent, as you can see from the following snap of the daily chart on this beast of a play, and the message from the chatroom at 9:53am.


Today, we would expect to see a gap-up followed by a significant dip as profit-takers exit their positions. From there, if properly timed, we could be looking at a big bounceplay, so we’ll want to keep RCHA on watch for at least the remainder of the week.

*Any readers who’d like to be involved in these trading chats in the future can do so easily! For either the Premium or the free chats, simply add “stocksumo” as a contact on Skype to request access!

Extended Watchlist (All Earnings Plays):
UA, GMCR, DATA

Blue Horseshoe Stocks: New Options Trading Ideas

Gilead Sciences, Inc. GILD
& Chipotle Mexican Grill, Inc. CMG – Options Ideas

We see potential opportunities in the options arena this mid-week, from a couple of stocks that we’re catching on the heels of their earnings calls. Despite earnings beats for both, each stock has actually fallen.

Gilead Sciences, Inc. GILD – Despite exceptional 2014 earnings, investors read between the lines on a number of other key aspects following last nights call, and as a result the stock is taking a bit of a beating. This morning’s premarket low stands at 90.60. That will be the price-point we’ll need to monitor to determine an options trading strategy. Should GILD sustain a recovery off of these lows, we’ll be looking at in-the-money Calls, most likely at the $97 and $98 levels. In the event that the stock begins to find new lows we’d need to flip our strategy to Put side of the fence.

Chipotle Mexican Grill, Inc. CMG – Here we have a similar situation, with CMG taking a beating in today’s premarket, having hit a low of $675. Like GILD, earnings expectations were exceeded, however shortcomings in sales and other key metrics has momentarily taken the wind out of CMG’s sails. This is another situation where we need to monitor the stock to ensure it doesn’t fall below the premarket low in order to secure our interest in playing the Calls. We’d obviously need to look at Puts if CMG were to backslide any further, but barring that occurrence, were going to be looking at Calls in the $675-$680 range.

Inergetics, Inc. NRTI

NRTI serves as a reminder of why it’s always a good idea to check our blog at Blue Horseshoe Stocks each morning even if you’ve consumed our report via email or elsewhere. The contents of our daily-updated Stock Tracker may or may not be included in that day’s report, and often those stocks we add at the last minute go on to provide big opportunities.

That was the case with NRTI yesterday; we placed it on the tracklist just minutes prior to the opening bell, and the stock made one heck of a move. From a low of .0115, it went on to touch a daily high of .02, marking a healthy intraday move of 74% on just over three times the 30-day average volume.

Extended Watchlist:
AAPT, BABB, DIS, GPRO(Earnings Tomorrow Post-Market)

Blue Horseshoe Stocks: PZOO Rehash


Pazoo, Inc. PZOO – Updates

Readers who have been following our reports at least since November will remember our talking about this stock, and since that time there have been several developments with Pazoo. For that reason we will be taking another look at PZOO this morning,  reviewing those updates the company has sent over the wires in the past several weeks.

When we first began tracking this play in the fall, the company had just begun to explore opportunities in the cannabis sector, and it has shown dedication to that goal by making significant progress in that area in recent months through its partly-owned partner, as well as a new wholly-owned subsidiary.

Nevada cannabis testing firm MA & Associates, in which PZOO holds a 40% interest, on December 11th announced the first purchase order of product testing from one of the state’s largest licensed growers, tentatively set to begin at the end of this month. >> VIEW PR

A week later, it was revealed that the agency had entered into another agreement to provide exclusive testing on all of their marijuana grown for the next two years. It will begin with 100,000 square feet of ‘grow’ (An estimated contract value of $1M/year) with the intention of expanding up to 875,000 sq.ft. of  in the next two years. >> VIEW PR

In another more recent development related to its expansion into the cannabis sector, PZOO added Harris Lee, LLC as a 100% Wholly-Owned Subsidiary which is also operates in the niche business of medical marijuana testing. >> View PR

*In addition to its growing involvement in the medical marijuana space, Pazoo still operates its health & wellness web portal and store at PAZOO.COM.  Its accompanying podcast, Pazoo Radio, is now up to its 9th episode, and includes a wide range of topics along and special guests >> GO TO PAZOO RADIO

PZOO CHART:

As a quick glance at the chart will show, it appears to be a good time to turn our focus to PZOO again from a technical standpoint as well. Lately, we’ve had quite a bit of good fortune relating to bottom plays rebounding off of their 52-week lows, and that’s precisely the position in which we now find this stock. We’ll initially be looking for PZOO to challenge primary resistance at the 50DMA of .0183.

We also want to highlight this morning’s PR regarding new members of management joining the team to help facilitate PZOO’s aggressively planned expansion into the marijuana testing business:

WHIPPANY, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to announce Antonio Del Hierro and David Lieberthal, Esq. have been nominated to its Board of Directors. >> FULL PR

More Information @ PAZOO.COM